Announcement Highlights | china overseas: Sales in October increased by 66% year-on-year; alibaba continues to repurchase approximately 19.9886 million US dollars of shares.

Concord Ne (00182.HK): The total power generation in the first 10 months was 7166.91GWh, a year-on-year increase of 12.79%; Poly Property: Sales revenue in October was 8.6 billion yuan.

cls.cnNov 6 19:37 ET

chinare pharma (03320.HK) completes acquisition of 100% equity of Green Cross HK

Gelonghui, November 6th | Chinares Pharma (03320.HK) announced that the board of directors happily announced that the share transfer registration with the relevant counterpart department of the State Administration for Market Regulation has been completed. Therefore, as of the date of this announcement, the acquisition of 100% equity of Green Cross HK is recommended to have been completed in accordance with the terms and conditions of the share purchase agreement. After completion, Green Cross HK becomes a wholly-owned subsidiary of China Resources Boya Bio-Pharmaceutical Group and is accounted for as a non-wholly-owned subsidiary of the Company.

Gelonghui FinanceNov 6 05:15 ET

Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)

The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.

Zhitong FinanceNov 3 20:45 ET

Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET

Chinares Pharma (03320): dong-e-e-jiao achieved a net income of 1.152 billion yuan in the first 9 months, a year-on-year increase of 46.74%.

chinares pharma (03320) released the performance for the nine months ending September 30, 2024, of dong-e-e-jiao, with total operating income...

Zhitong FinanceOct 30 08:35 ET

CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFDONG-E-E-JIAO FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

HKEXOct 30 08:23 ET · Announcements